Stocks and Investing Stocks and Investing
Thu, November 19, 2020
Wed, November 18, 2020
Tue, November 17, 2020
Mon, November 16, 2020
Fri, November 13, 2020

Matthew Gillmor Upgraded (TDOC) to Buy and Held Target at $220 on, Nov 13th, 2020


Published on 2024-10-27 14:46:15 - WOPRAI, Matthew Gillmor
  Print publication without navigation


Matthew Gillmor of Baird, Upgraded "Teladoc Health, Inc." (TDOC) to Buy and Held Target at $220 on, Nov 13th, 2020.

Matthew has made no other calls on TDOC in the last 4 months.



There are 11 other peers that have a rating on TDOC. Out of the 11 peers that are also analyzing TDOC, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jamie Stockton of "Wells Fargo" Maintained at Hold with Increased Target to $200 on, Thursday, October 29th, 2020
  • David Grossman of "Stifel" Maintained at Hold with Increased Target to $205 on, Thursday, July 30th, 2020


These are the ratings of the 9 analyists that currently disagree with Matthew


  • Donald Hooker of "Keybanc" Maintained at Buy with Increased Target to $245 on, Thursday, October 29th, 2020
  • George Hill of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $244 on, Thursday, October 29th, 2020
  • Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $261 on, Thursday, October 29th, 2020
  • Stephanie Davis of "SVB Leerink" Maintained at Buy with Increased Target to $256 on, Thursday, October 29th, 2020
  • Hannah Baade of "DA Davidson" Initiated at Strong Buy and Held Target at $250 on, Tuesday, September 22nd, 2020
  • Jailendra Singh of "Credit Suisse" Upgraded from Hold to Buy and Increased Target to $249 on, Monday, August 17th, 2020
  • Sean Dodge of "RBC Capital" Maintained at Buy with Increased Target to $235 on, Thursday, July 30th, 2020
  • Sean Wieland of "Piper Sandler" Maintained at Buy with Increased Target to $232 on, Thursday, July 30th, 2020
  • John Eade of "Argus Research" Initiated at Strong Buy and Held Target at $280 on, Monday, July 13th, 2020